Implantology.  2019 Dec;23(4):214-219. 10.32542/implantology.2019018.

Progressive Hemifacial Atrophy After Implant Placement in Patients Taking Immunosuppressive Agents: Case Report

Affiliations
  • 1Clinical Instructor, Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital, Yonsei University College of Dentistry, Seoul, Korea.
  • 2Clinician, Yonsei Allbareun Dental Clinic, Yongin-si, Korea.
  • 3Clinical Associate Professor, Department of Oral and Maxillofacial Radiology, Yonsei University College of Dentistry, Seoul, Korea.
  • 4Professor, Department of Oral and Maxillofacial Surgery, Gangnam Severance Hospital, Yonsei University College of Dentistry, Seoul, Korea. omshuh@yuhs.ac

Abstract

Progressive hemifacial atrophy (PHA) is a rare disorder characterized by acquired unilateral facial atrophy. This disease mainly affects the skin and the craniofacial tissue below forehead. It also involves dermatomes of the fifth cranial nerve. Atrophy of subcutaneous tissue, fat, muscle and osseocartilaginous structures were seen. It resulted in a sunken hemifacial appearance. Although epidermal cutaneous tissue was minimally involved, the tongue, gingiva, teeth, and palate may also be affected. The purpose of this study is to report a case of progressive hemifacial atrophy in a patient taking immunosuppressive drugs after implant and sinus graft surgery.

Keyword

Dental implant; Hemifacial atrophy; Immunosuppressive agents; Maxillary sinus floor augmentation

MeSH Terms

Atrophy
Dental Implants
Facial Hemiatrophy*
Forehead
Gingiva
Humans
Immunosuppressive Agents*
Palate
Sinus Floor Augmentation
Skin
Subcutaneous Tissue
Tongue
Tooth
Transplants
Trigeminal Nerve
Dental Implants
Immunosuppressive Agents
Full Text Links
  • IMP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr